MA26569A1 - Nouvelles formes pseudopolymorphiques de dichlorhydrate d'acide 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl] ethoxy]acetique - Google Patents

Nouvelles formes pseudopolymorphiques de dichlorhydrate d'acide 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl] ethoxy]acetique

Info

Publication number
MA26569A1
MA26569A1 MA25361A MA25361A MA26569A1 MA 26569 A1 MA26569 A1 MA 26569A1 MA 25361 A MA25361 A MA 25361A MA 25361 A MA25361 A MA 25361A MA 26569 A1 MA26569 A1 MA 26569A1
Authority
MA
Morocco
Prior art keywords
piperazinyl
fluorophenyl
ethoxy
acetic
bis
Prior art date
Application number
MA25361A
Other languages
English (en)
Inventor
Monique Berwaer
Michel Deleers
Charles Dogimont
Jacques Timmermans
Guy Bodson
Domenico Fanara
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of MA26569A1 publication Critical patent/MA26569A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA25361A 1997-11-26 1998-11-25 Nouvelles formes pseudopolymorphiques de dichlorhydrate d'acide 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl] ethoxy]acetique MA26569A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (fr) 1997-11-26 1997-11-26 Formes pseudopolymorphiques de l'acide 2-2-4-bis(4-fluorophényl)méthyl -1-pipérazinyl-éthoxy acétique dihydrochloride

Publications (1)

Publication Number Publication Date
MA26569A1 true MA26569A1 (fr) 2004-12-20

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25361A MA26569A1 (fr) 1997-11-26 1998-11-25 Nouvelles formes pseudopolymorphiques de dichlorhydrate d'acide 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl] ethoxy]acetique

Country Status (39)

Country Link
US (2) US6262057B1 (fr)
EP (2) EP0919550A1 (fr)
JP (2) JP3996348B2 (fr)
KR (1) KR100557711B1 (fr)
CN (1) CN100406448C (fr)
AR (1) AR017676A1 (fr)
AT (1) ATE203237T1 (fr)
AU (1) AU735819B2 (fr)
BG (1) BG64155B1 (fr)
BR (1) BR9815405A (fr)
CA (1) CA2310318C (fr)
CO (1) CO4980892A1 (fr)
CZ (1) CZ295972B6 (fr)
DE (1) DE69801163T2 (fr)
DK (1) DK1034171T3 (fr)
EG (1) EG23776A (fr)
ES (1) ES2161552T3 (fr)
GC (1) GC0000094A (fr)
GR (1) GR3036702T3 (fr)
HU (1) HUP0100343A3 (fr)
ID (1) ID24964A (fr)
IL (1) IL135544A (fr)
MA (1) MA26569A1 (fr)
MY (1) MY119653A (fr)
NO (1) NO314692B1 (fr)
NZ (1) NZ504461A (fr)
PE (1) PE134899A1 (fr)
PL (1) PL190871B1 (fr)
PT (1) PT1034171E (fr)
RS (1) RS49904B (fr)
RU (1) RU2182575C2 (fr)
SI (1) SI20325A (fr)
SK (1) SK283237B6 (fr)
TN (1) TNSN98214A1 (fr)
TR (1) TR200001505T2 (fr)
TW (1) TWI225053B (fr)
UA (1) UA54568C2 (fr)
WO (1) WO1999028310A1 (fr)
ZA (1) ZA9810780B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
EP1414460A1 (fr) * 2001-07-26 2004-05-06 Ucb, S.A. Procede de fabrication de derives d'acides 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazine-1-yl)ethoxy)acetiques ou de sels de ces composes et intermediaires correspondants
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
JP5160018B2 (ja) * 2002-06-25 2013-03-13 アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド 非晶質医薬組成物を用いる経皮送達速度調節
US20070185122A1 (en) * 2003-05-28 2007-08-09 Christophe Revirron Use of efletirizine for treating persistent allergic rhinitis
WO2006050909A1 (fr) * 2004-11-10 2006-05-18 Ucb Farchim Sa Nouvelles formes du dichlorhydrate d’efletirizine, procédés de synthèse desdites formes et préparations pharmaceutiques les incluant
WO2008155777A2 (fr) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Procédé de préparation de l'efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
FI75816C (fi) 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
UA8337A1 (uk) * 1981-02-06 1996-03-29 Бальтес Ежен 2-[4-(дифенілметіл)-1-піперазиніл]-оцтові кислоти або їх аміди, або їх нетоксичні фармацевтично прийняті солі, що проявляють спазмолітичну і антигістамінну активність
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.

Also Published As

Publication number Publication date
MY119653A (en) 2005-06-30
PT1034171E (pt) 2001-11-30
US20010021712A1 (en) 2001-09-13
ES2161552T3 (es) 2001-12-01
PL190871B1 (pl) 2006-02-28
EG23776A (en) 2007-08-08
ZA9810780B (en) 1999-05-31
JP2007224042A (ja) 2007-09-06
SI20325A (sl) 2001-02-28
JP2001524548A (ja) 2001-12-04
IL135544A0 (en) 2001-05-20
RU2182575C2 (ru) 2002-05-20
NO20002631L (no) 2000-05-23
NZ504461A (en) 2001-06-29
CN1279676A (zh) 2001-01-10
PL340724A1 (en) 2001-02-26
ATE203237T1 (de) 2001-08-15
TWI225053B (en) 2004-12-11
DE69801163D1 (en) 2001-08-23
CA2310318C (fr) 2003-10-21
CA2310318A1 (fr) 1999-06-10
EP1034171A1 (fr) 2000-09-13
US6262057B1 (en) 2001-07-17
KR100557711B1 (ko) 2006-03-07
TR200001505T2 (tr) 2000-09-21
BG64155B1 (bg) 2004-02-27
US6335331B2 (en) 2002-01-01
PE134899A1 (es) 2000-01-11
AR017676A1 (es) 2001-09-12
CZ295972B6 (cs) 2005-12-14
TNSN98214A1 (fr) 2005-03-15
JP3996348B2 (ja) 2007-10-24
BG104424A (en) 2001-01-31
HUP0100343A2 (hu) 2001-07-30
EP0919550A1 (fr) 1999-06-02
KR20010032420A (ko) 2001-04-16
NO20002631D0 (no) 2000-05-23
DE69801163T2 (de) 2002-03-28
BR9815405A (pt) 2000-10-10
DK1034171T3 (da) 2001-11-05
SK5942000A3 (en) 2000-10-09
AU735819B2 (en) 2001-07-19
GR3036702T3 (en) 2001-12-31
HUP0100343A3 (en) 2001-09-28
WO1999028310A1 (fr) 1999-06-10
EP1034171B1 (fr) 2001-07-18
SK283237B6 (sk) 2003-04-01
YU31600A (sh) 2002-03-18
RS49904B (sr) 2008-08-07
CO4980892A1 (es) 2000-11-27
CZ20001787A3 (cs) 2000-09-13
IL135544A (en) 2004-02-08
AU1327799A (en) 1999-06-16
GC0000094A (en) 2005-06-29
ID24964A (id) 2000-08-31
UA54568C2 (uk) 2003-03-17
CN100406448C (zh) 2008-07-30
NO314692B1 (no) 2003-05-05

Similar Documents

Publication Publication Date Title
FI963218A7 (fi) Mykofenolihapon 5-substituoidut johdannaiset
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
NO993836D0 (no) Arylsulfonyl-hydroksamsyre-derivater
DE59505055D1 (de) Dermal applizierbare formulierungen von parasitiziden
EP1210358A4 (fr) Detection d'acides nucleiques
BR9605309A (pt) Composições de derivados piperazina
EP1114827A4 (fr) Nouvelle paire de bases d'acide nucleique
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
NO20015828L (no) Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater
NO20002686L (no) Forbedring av Peyronies sykdom
DK0927173T3 (da) Substituerede [2-(1-piperazinyl)ethoxy]methylforbindelser
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
NO20002631D0 (no) Pseudopolymorfe former av 2-[2-[4-(bis(4-fluorfenyl)metyl]-1- piperazinyl]etoksy]eddiksyre dihydroklorid
DK0713648T3 (da) Hidtil ukendt sammensætning af hævesyrer
FI951128L (fi) Substituoituja N-etyyliglysiinijohdannaisia PNA- ja PNA-/DNA-hybridien valmistamiseksi
EP1449823A4 (fr) Diester d'acide dibasique
BR9603916A (pt) Derivados de ácido 2-(pirazolióxi-pirimidin-5-il) acético
EP1086119A4 (fr) Purification d'anticorps
NO995841L (no) Fremgangsmåte for fremstilling av 3-(7-amidino-2-naftyl)-2- fenylpropionsyre-derivater
ES2074472T3 (es) Procedimiento de preparacion de un derivado de la 1,4-dihidro-piridina, la (-)-2-((2-(2-amino-etoxi)-etoxi)-metil)-4-(2,3-dicloro-fenil)-3-etoxi-carbonil-5-metoxi-carbonil-6-metil-1,4-dihidro-piridina y de sus sales.
ATE230413T1 (de) Pharmazeutisch verträgliche salze von 3-hydroxy- estr-5(10)-en-17-on-3-sulfat die als östrogene aktiv sind
FR2793140B1 (fr) Utilisation de fragments d'acide hyaluronique
SE9802197D0 (sv) Formulations of busulphan
UA3711S (uk) Сувенір "святиня"
UA1629S (uk) Набір фестонів "веснянка-5"